One video visit
All states
GLP-1 weight loss in New Jersey
- Visit type
- No video visit required
- Licensing
- New Jersey State Board of Medical Examiners
- Updated
- Licensed by
- New Jersey State Board of Medical Examiners
- Telehealth
- No video visit required
- Semaglutide injections
- Available
- Tirzepatide injections
- Available
- Medicaid
- Limited coverage
- Shipping
- 2–3 business days
New Jersey residents can now access GLP-1 medications like semaglutide and tirzepatide through telehealth — without crossing the Hudson, scheduling weeks out at a Bergen or Essex County clinic, or fighting with insurance. Pallas Health pairs you with a board-certified provider licensed in New Jersey who reviews your intake — by secure message in most cases — and if appropriate sends a prescription to a compounding pharmacy that ships to any New Jersey address in a few business days.
How telehealth prescribing works in New Jersey
New Jersey permits licensed providers to establish the provider-patient relationship and prescribe non-controlled medications like GLP-1s through telehealth — including asynchronous review of your intake — when the standard of care is met, under the New Jersey Telemedicine and Telehealth Act.
New Jersey requires any provider prescribing to a New Jersey resident to hold an active New Jersey medical license. Under the New Jersey Telemedicine and Telehealth Act (P.L. 2017, c. 117) and State Board of Medical Examiners regulations, a licensed provider may establish the provider-patient relationship and prescribe non-controlled medications like GLP-1s through telehealth, including synchronous video and, in appropriate cases, asynchronous review, provided the standard of care is met. Every Pallas provider who treats New Jersey patients holds an active New Jersey medical license; depending on your history, a provider may follow up by message, video, or request additional labs before prescribing. GLP-1s are not controlled substances, so New Jersey's separate NJPMP and controlled-substance telemedicine requirements don't add friction here, but our providers still document a complete history, screen for contraindications like personal or family history of medullary thyroid carcinoma, and schedule follow-up visits to monitor response and titrate the dose.
Medicaid & insurance in New Jersey
NJ FamilyCare (New Jersey Medicaid) covers GLP-1s for type 2 diabetes with prior authorization. Coverage for weight-management indications is limited. Compounded GLP-1s are not covered. Pallas is a cash-pay telehealth service. Medicaid and private insurance do not apply to our prescriptions; pricing is flat and disclosed up front.
Simple cash-pay pricing in New Jersey
No insurance, and the same price in every New Jersey ZIP code. You see your full price during intake, before you pay anything. One plan price covers your US-licensed provider, check-ins, dose adjustments and care-team messaging, with no membership fee. Medication ships free, and nothing is charged until a clinician prescribes. Cancel anytime. Your clinician helps determine which option is appropriate for you.
Compounded
- Semaglutide injectionsFrom $139
- Tirzepatide injectionsFrom $179
Brand-name
- Wegovy® injectionsFrom $499
- Zepbound® injectionsFrom $499
- Ozempic® injectionsFrom $499
- Mounjaro® injections$1,099/mo
- Wegovy® pillFrom $299
- Foundayo™ pillFrom $299
Semaglutide vs tirzepatide in New Jersey
Both are once-weekly injections available to New Jersey patients through Pallas, as compounded preparations and as the FDA-approved brand-name products. They work differently: semaglutide activates the GLP-1 receptor, while tirzepatide activates both the GLP-1 and GIP receptors — two of the gut hormones that regulate appetite and fullness.
In SURMOUNT-5, the head-to-head clinical trial of the FDA-approved products, Zepbound® (tirzepatide 10 mg or 15 mg weekly) produced greater average weight loss than Wegovy® (semaglutide 1.7 mg or 2.4 mg weekly) — 20.2% versus 13.7% of body weight over 72 weeks — with broadly similar tolerability. That trial predates Wegovy®'s higher 7.2 mg weekly dose, which reached 18.7% average weight loss over 72 weeks in the separate STEP UP trial; separate trials do not provide a direct comparison. Clinical trial outcomes for the FDA-approved products have not been established for compounded preparations. Individual results vary.
Cost and track record differ too: compounded semaglutide renews at $199 every 4 weeks versus $299 for tirzepatide (full terms in the questions below), and semaglutide has the longer post-market record. Which medication fits your health history, goals, and budget is a decision you make with a clinician licensed in New Jersey — our full semaglutide vs tirzepatide comparison covers the deeper differences.
Cities served in New Jersey
Partner pharmacies ship to every ZIP code in New Jersey, including:
- Newark
- Jersey City
- Paterson
- Elizabeth
- Edison
- Lakewood
- Toms River
- Trenton
New Jersey GLP-1 questions
Start the online intake (about 5 minutes). A New Jersey-licensed clinician reviews it by secure message, and if a GLP-1 is appropriate, a US-licensed pharmacy ships it to you in 2–3 business days.
Same intake as semaglutide. If appropriate, a New Jersey-licensed clinician can prescribe compounded tirzepatide or FDA-approved Zepbound® or Mounjaro®, and explains which fits you.
No. New Jersey allows a licensed clinician to review your intake by secure message and prescribe without a scheduled video call. They may ask for a video visit only if your history calls for it.
Yes. A New Jersey-licensed clinician can prescribe it for you with a documented clinical reason, and a US-licensed compounding pharmacy prepares it per patient. Brand-name Wegovy® is also available.
Yes. New Jersey nurse practitioners prescribe independently, with no physician agreement required. GLP-1s are not controlled substances, so they can be prescribed by telehealth.
Several do. Check that its clinicians are licensed in New Jersey, that it uses US-licensed compounding pharmacies, and that it is LegitScript-certified. Pallas serves New Jersey.
NJ FamilyCare (New Jersey Medicaid) covers GLP-1s for type 2 diabetes with prior authorization. Compounded GLP-1s are not covered. Pallas is cash-pay, so Medicaid rules do not apply.
Most New Jersey patients receive their medication within 2–3 business days of the pharmacy filling the prescription. Newark and Jersey City ship fastest; rural ZIP codes may take an extra day.
A New Jersey-licensed clinician decides after reviewing your intake. GLP-1s are generally considered at a BMI of 30 or more, or 27 or more with a condition like high blood pressure.
Wegovy®, Ozempic®, Zepbound® and Mounjaro® are FDA-approved. Compounded semaglutide and tirzepatide are made per patient by US-licensed pharmacies and are not FDA-approved. Your clinician decides.
Yes. Tell your clinician your current medication, dose and everything else you take during intake. If appropriate, they continue you at a comparable dose. Don't change a prescription on your own.
Most patients use a once-weekly injection with a very fine needle. A daily tablet is available on request. Your clinician confirms which form is appropriate for you.
Mostly stomach-related: nausea, constipation or diarrhea, usually mildest when the dose is raised slowly. They are avoided in pregnancy and with a personal or family history of medullary thyroid cancer or MEN2.
You answer health questions online in about 5 minutes. A New Jersey-licensed clinician reviews it by secure message, and if a GLP-1 is appropriate, a licensed pharmacy ships it in 2–3 business days.
Your first order arrives in 2–3 business days, and most patients start low and step up gradually. Your plan renews on a set schedule so refills arrive before you run out; change or cancel anytime in the portal.
Compounded semaglutide injections are $139 first month, then $199 every 4 weeks, charged once a clinician prescribes. Cancel anytime. Your clinician, check-ins and messaging are included; shipping is free.
Compounded tirzepatide injections are $179 first month, then $299 every 4 weeks, charged once a clinician prescribes. Cancel anytime. Your clinician, check-ins and messaging are included; shipping is free.
Yes. Wegovy®, Zepbound® and Foundayo™ are FDA-approved for weight management, Ozempic® and Mounjaro® for type 2 diabetes. All are cash-pay: pens from $499 first month, daily pills from $299.
NJ FamilyCare (New Jersey Medicaid) covers GLP-1s for type 2 diabetes with prior authorization. Compounded GLP-1s are not covered. Pallas is cash-pay, so Medicaid rules do not apply.
Two cash-pay paths: stay on Wegovy® or Zepbound® from $499 first month, or a compounded plan from $139 first month if a licensed clinician finds it appropriate. Tell your clinician your current dose.
A decision for you and your clinician. Semaglutide costs less and has the longer track record; tirzepatide acts on two gut-hormone receptors instead of one. The comparison above covers the trials.
Pallas serves all of New Jersey with one price for compounded semaglutide: $139 first month, then $199 every 4 weeks, charged once a clinician prescribes. Cancel anytime. No video visit is required.
Rule changes affecting New Jersey
No rule changes affecting New Jersey since this tracker began on May 29, 2026; the requirements shown here have held steady over that period.
From our state-by-state rules tracker. Get an email when a rule changes.
Pallas offers both FDA-approved and compounded medications. Compounded medications are not FDA-approved and are not generic versions of brand-name drugs. Eligibility and treatment are determined by a US-licensed clinician; results vary. Private pay only (no insurance). Operated by Brentmoor, Inc.